Abstract
Lymphoma is a systemic malignancy, originating from the lymphatic system, which accounts for 3 to 4% of all tumors. There are two major subtypes of lymphoma, namely, diffuse large B-cell lymphoma (DLBCL) and Hodgkin's lymphoma (HL). Elucidation of the pathogenesis of these two lymphoma types is crucial for the identification of potential therapeutic targets. Compared with the corresponding knowledge of other diseases, the understanding of the regulatory networks involved in DLBCL and HL is relatively deficient. To address this, we comprehensively analyzed the mRNAs, lncRNAs, and miRNAs that were differentially expressed between normal and tumor samples of DLBCL and HL. In addition, functional enrichment analysis of the differentially expressed mRNAs was performed. We constructed two specific ceRNA networks of DLBCL and HL. The pathways enriched by dysregulated mRNAs in DLBCL and HL were mainly involved in immune responses, transcription process, and metabolism process. The ceRNA network analysis revealed that 45 ceRNAs were shared between the two ceRNA networks, including five pivotal lncRNAs (MALAT1, CTBP1-AS, THUMPD3-AS, PSMA3-AS1, and NUTM2A-AS1). In addition, we proposed a DLBCL survival risk model based on a DLBCL-specific...Continue Reading
References
Jan 6, 2005·The American Journal of Pathology·Cigdem AtayarAnke van den Berg
Sep 2, 2006·Blood·Shahab UddinKhawla S Al-Kuraya
Dec 17, 2008·Nature Reviews. Cancer·Ralf Küppers
Oct 16, 2010·Breast Cancer Research : BCR·Christina YauChristopher C Benz
Mar 4, 2011·Nature·Christian SteidlRandy D Gascoyne
Apr 20, 2011·Leukemia·A WatanabeK Sawada
Aug 2, 2011·Cell·Leonardo SalmenaPier Paolo Pandolfi
Jul 5, 2012·Blood·Lorena Di LisioMiguel A Piris
Jul 4, 2013·BMC Cancer·Sarah A AndresJames L Wittliff
Oct 15, 2013·Blood Cancer Journal·S CaramutaW-O Lui
Dec 4, 2013·Nature Reviews. Genetics·Alessandro Fatica, Irene Bozzoni
Dec 4, 2013·Nucleic Acids Research·Jun-Hao LiJian-Hua Yang
Mar 4, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Mustafa IsinNejat Dalay
Jun 20, 2014·Oncology Letters·Ziru LiuSenlin Chen
Mar 25, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Karen DybkærHans E Johnsen
Aug 26, 2015·Nucleic Acids Research·Juan XuXia Li
Dec 25, 2015·Oncotarget·Shu-Yang WangYan-Qing Ding
Apr 29, 2016·Molecular Medicine Reports·Yuling YanMinglin Wang
May 26, 2016·Seminars in Cancer Biology·Marc A Weniger, Ralf Küppers
Aug 9, 2016·Seminars in Hematology·Stephan MathasRalf Küppers
Nov 22, 2016·Primary Care·Emiliano N Mugnaini, Nilanjan Ghosh
Dec 31, 2016·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Ben Dhiab MyriamTrimeche Mounir
Jan 21, 2017·Molecular Cancer·Meng ZhouJie Sun
Aug 2, 2017·Cancer Letters·Carla SoléCharles Henderson Lawrie
Oct 7, 2017·Cell·Anupama ReddySandeep S Dave
Jun 15, 2018·Biochimica Et Biophysica Acta. General Subjects·Kamalika SenTapash Chandra Ghosh
Sep 8, 2018·Advances in Experimental Medicine and Biology·Yongsheng LiJuan Xu
Sep 13, 2018·CA: a Cancer Journal for Clinicians·Freddie BrayAhmedin Jemal
Sep 28, 2018·Genes & Diseases·Heng XiaoChengyou Du
Oct 5, 2018·Nucleic Acids Research·Zhenyu BaoDong Dong
Oct 27, 2018·Nucleic Acids Research·Zhou HuangQinghua Cui
Nov 9, 2018·Nucleic Acids Research·Yue GaoXia Li
Nov 16, 2018·Pathology Oncology Research : POR·Yi ZhuXian Shen
Jan 6, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hongxia XuWenzhuo Zhuang
Mar 13, 2019·American Journal of Hematology·Yang Liu, Stefan Klaus Barta
Mar 23, 2019·Life Sciences·Qing-Ming WangYi Gong
Jan 15, 2020·Signal Transduction and Targeted Therapy·Juanjuan KangJian Huang
Apr 17, 2020·Signal Transduction and Targeted Therapy·Juanjuan KangJian Huang